AzTrials
AzTrials

Cancer Risk FactorsCARES4YouNCT07501689

Using Middle School Science Teachers to Address Cancer Health Disparities

A study testing CARES4You Curriculum in people with Cancer Risk Factors and Cancer Prevention, run by Weill Medical College of Cornell University at 5 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The CARES4You study is testing a middle school science curriculum designed to teach students about cancer risk and prevention. The lessons are taught by regular science teachers during class time and are aligned with national science education standards. Read more about this study

Who is it for?
Ages 10 years and olderHealthy volunteers can take part
Conditions the study is for
Cancer Risk Factors, Cancer Prevention
What is being tested?
CARES4You Curriculum
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
1,812 participants
Where
5 sitesUnited States
Study dates
29 Jan 2026to 30 Jun 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Adolescents:
  • Age 10-13
  • Attends a NYC Public Middle School
  • Resides in one of the study's four target PPA's
  • Parents/Caregivers:
  • 18 years of age or older
Show all 9Show fewer
  • Has at least one child registered for middle school in NYC that resides with them
  • Resides in one of the study's four target PPA's
  • Able to provide informed consent

Who cannot join

  • Adolescents: Students who do not attend one of the participating NYC Public Middle Schools
  • Parents/Caregivers: Caregivers who do not have a child that attends one of the participating NYC Public Middle Schools

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Alia Komsany, PhD contact

646-962-5036

alk4019@med.cornell.edu

5 sites in 1 country

United States5 sites, 2 recruiting
  • Dock Street School for STEAM Studies District: 13 School #: K313

    Brooklyn, New York, 11201

    Active, not recruiting
  • P.S/I.S. 173 District: 6 School #: 173

    New York, New York, 10033

    Erica Phillips, MD, MS, 646-962-5013, erp2001@med.cornell.edu

    Recruiting
  • I.S. 145 Joseph Pulitzer District 30 School #: Q145

    Queens, New York, 11372

    Active, not recruiting
  • Metropolitan Expeditionary Learning School District 28 School #: Q167

    Queens, New York, 11375

    Active, not recruiting
  • Jonas Bronck Academy District: 7 School #: X043

    The Bronx, New York, 10458

    Erica Phillips, MD, MS, 646-962-5013, erp2001@med.cornell.edu

    Recruiting

Other trials in United States

About this study

Official title: Using Middle School Science Teachers to Address Health Disparities

The CARES4You study is testing a middle school science curriculum designed to teach students about cancer risk and prevention. The lessons are taught by regular science teachers during class time and are aligned with national science education standards. The curriculum includes six units (14 lessons) that help students learn about cancer, understand how lifestyle and environmental factors influence risk, and think about ways to make healthy choices.

The study will take place in 10 public middle schools in New York City. Some schools will begin using the CARES4You curriculum right away, while others will continue with their usual science lessons and receive the program later. Researchers will compare the two groups of schools.

Read more

The main goal of the study is to see whether the curriculum increases students' intentions to engage in healthy behaviors that may reduce cancer risk. The study will also examine whether students talk more with their caregivers about cancer risk and prevention after participating in the program. Caregivers may also report on some health behaviors in the household.

If the program is effective, CARES4You could provide schools with a practical and sustainable way to teach cancer prevention and promote healthy behaviors among adolescents and their families.

Read the detailed description

The investigators will evaluate whether the CARES4You intervention modifies health-promoting behavior intentions among middle school students in New York City.

Participants in the control arm will receive the exact same 5-week educational curriculum as those in the intervention arm.

Participants will:

  1. Be assigned to either the control group or the study group; both will receive the same cancer educational curriculum over 5 weeks.
  2. Receive weekly classroom lessons and labs over 5 weeks.
  3. Students will complete a survey before and after the administration of the curriculum intervention. These questionnaires evaluate students' change in knowledge related to the curriculum, and questions about their cancer risk behaviors, and communication styles at home.
  4. Caregivers of students in the intervention schools only will complete a survey at one time point and receive a $40 electronic gift card for completing the survey at the end of the curriculum implementation phase.
  5. Instructors will complete a training program evaluation and a post-curriculum evaluation to assess the impact of the curriculum on their students.
Being tested
CARES4You Curriculum
Keywords
cancer prevention, cluster trial, adolescent health, school-based intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CARES4You CurriculumBehavioural

    CARES4You is a teacher-delivered middle school science curriculum focused on cancer risk and prevention. Public middle schools in New York City self-select into either an immediate-intervention group or a delayed-intervention group. In both groups, grade-level science teachers deliver the same curriculum during regular 50-minute science classes over approximately five weeks. The program includes six units delivered across 14 lessons, typically taught 4-5 days per week. Units cover Cancer Genetics, Cancer Epidemiology, Media Literacy and Tobacco Advertising, Nutrition and Cancer, Biotechnology and Cancer, and Cancer Risk Reduction. Lessons combine brief instruction with interactive activities such as identifying cancer risk factors and discussing ways families can reduce risk. Students also complete a final cumulative project.

Study groups in NCT07501689
Study groupRoleWhat they receive
Immediate Intervention DeliveryExperimentalStudents in the immediate intervention group will receive the CARES4You curriculum as part of their regular science class. They will complete study assessments before the curriculum begins (baseline) and again approximately six weeks later, after the curriculum has been delivered. Caregivers will complete a one-time survey about cancer risk communication in the household and their own health behaviors approximately two weeks after the curriculum has been completed in their child's classroom.
Receives: Behavioral: CARES4You Curriculum
Delayed Intervention DeliveryPlacebo comparatorSchools assigned to the delayed intervention group will continue with their usual science curriculum during the initial study period. Students will complete the same study assessments as the intervention group at baseline and approximately six weeks later. After completion of the follow-up assessments, these schools will implement the CARES4You curriculum the following semester or academic year.
Receives: Behavioral: CARES4You Curriculum

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in students' intention to engage in health-promoting behaviors following the completion of the curriculum.

    Intent to engage in health-promoting behaviors will be assessed by an adapted nine-item instrument. The response scale for each question item ranges from 0 (does not apply to me) to 3 (very likely) with a sum score ranging from 0 to 27. Higher scores represent a greater intention to follow health-promoting behaviors.

    Measured: Baseline, End of Study (6 weeks)

Secondary outcomes (1)
  1. Number of student participants and caregiver participants who initiate cancer risk communication in the household.

    Cancer risk communication will be assessed by a one item instrument. The response scale for the question ranges from 0 (no) to 1 (yes) with a yes indicating if the student participant has spoken with a caregiver participant about cancer.

    Measured: End of Study (6 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2026
  2. Study start29 Jan 2026
  3. Primary completion30 Jun 2028 (estimated)
  4. Study completion30 Jun 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Pragmatic cluster non-randomized trial
Masking
None (open label)
Enrolment
1,812 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07501689
Sponsor's protocol ID
22-12025527
Other IDs
U54CA280808-01, NYC DOE 4928
Acronym
CARES4You
Status last verified
Mar 2026
First submitted
24 Mar 2026
Last updated
30 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie the results reported in any publication will be shared after deidentification (text, tables, figures, and appendices).

Publications

  • Komsany A, McCooty K, Fox J, Shah U, Leak TM, McDonald JA, Terry MB, Soroka O, Phillips E. Integrating Cancer Prevention into Science Education: Development of the CARES4You School-based Curriculum. J Cancer Educ. 2025 Dec 22:10.1007/s13187-025-02812-x. doi: 10.1007/s13187-025-02812-x. Online ahead of print.

    PubMed 41428312

Questions about this trial

What is this clinical trial studying?

A study testing CARES4You Curriculum in people with Cancer Risk Factors and Cancer Prevention, run by Weill Medical College of Cornell University at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Rosio Ramos, BA (646 962 5037, ror2023@med.cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in students' intention to engage in health-promoting behaviors following the completion of the curriculum. (time frame: Baseline, End of Study (6 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07501689, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in